Patent · US Expired

New mitomycin derivatives, preparation thereof and pharmaceutical compositions containing them

US4691024A · kind A · utility

63Cited by
0References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 3, 1986
Grant dateSep 1, 1987
Priority date
Expiry dateOct 3, 2006

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides new mitomycin derivatives of general formula (I) ##STR1## [wherein Y and Z, which may be the same or different, each represents a hydrogen atom or a methyl group; PA1 represents .alpha. or .beta. bonding and X represents a group of formula (II) ##STR2## (wherein R.sub.1 to R.sub.5 are each selected from hydrogen, halogen, hydroxyl, nitro, amino, lower alkyl, lower alkoxy, lower alkylamino or lower alkanoylamino); PA1 or an S-yl group of an amino acid having a thiol group, the carboxyl group optionally being protected e.g. in the form of a lower alkyl ester group and the amino group optionally being protected e.g. in the form of a lower alkanoylamino group; PA1 or an S-yl group of a di- or tripeptide containing an amino acid residue with a thiol group, the carboxyl group optionally being protected e.g. in the form of a lower alkyl ester and the amino group optionally being protected e.g. in the form of a lower alkanoylamino group]; and salts thereof. Such mitomycin derivatives have improved anti-bacterial and anti-tumor activities and low toxicity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.